Mary Elizabeth M. Younger, Ph.D., M.A.
People with primary or secondary immunodeficiencies; immunoglobulin replacement therapy; psychosocial issues faced by people with immunodeficiencies ...read more
Dr. Mary Elizabeth Younger is an assistant professor of pediatrics at the Johns Hopkins School of Medicine.
Dr. Younger received her undergraduate degree from the University of Virginia. She earned her master’s degree from New York University and a Ph.D. from the University of Virginia.
Wasserman, R.L., Stein, M. R., Younger, M.E.M., Fatteh, S. & Haddad, E. (2016). 20% Subcutaneous immunoglobulin dosed biweekly for primary immunodeficiency. Annals of Allergy, Asthma and Immunology, 117(1), 93-94
Ballow, M., Sriaroon, P., Rachid, R., Seeborg, F., Duff, C., Bonilla, F., Younger, M. E. M., & Shapiro, R. (2017). Construction and Validation of a Disease-specific Quality of Life (HR-QOL) Instrument for Patients with Primary Antibody Deficiency Disease. Journal of Allergy and Clinical Immunology
Younger, M. E. M., Aro, L., Blouin, W., Duff, C., Epland. K. B., Murphy, E., & Sedlak, D. Nursing guidelines for administration of immunoglobulin replacement therapy. Journal of the Infusion Nurses Society 2013; 36(1), 58-68
Younger, M.E.M., Epland, K., Zampelli, A., & Hintermeyer, M.K. Identification, evaluation and management of primary immunodeficiency diseases: A review for primary care providers. The Nurse Practitioner 2015, 40(2):1-7
Younger, M. E. M., Blouin, W., Duff, C., Epland, K. B., Murphy, E., & Sedlak, D. Subcutaneous immunoglobulin replacement therapy: Ensuring success. Journal of Infusion Nursing 2015, 38(1), 70-79
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.